These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 9864419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma.
    Mejia MC, Navarro S, Pellin A, Castel V, Llombart-Bosch A.
    Anticancer Res; 1998; 18(2A):801-6. PubMed ID: 9615722
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of bcl-2 gene product in neuroblastoma.
    Ramani P, Lu QL.
    J Pathol; 1994 Mar; 172(3):273-8. PubMed ID: 8195931
    [Abstract] [Full Text] [Related]

  • 6. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 7. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K, Fujioka T, Kitagawa H, Takakuwa T, Yamate N.
    Jpn J Clin Oncol; 1993 Jun 15; 23(3):149-55. PubMed ID: 8350488
    [Abstract] [Full Text] [Related]

  • 8. N-myc amplification and cell proliferation rate in human neuroblastoma.
    Pession A, Trerè D, Perri P, Rondelli R, Montanaro L, Mantovani W, Derenzini M, Paolucci G.
    J Pathol; 1997 Nov 15; 183(3):339-44. PubMed ID: 9422991
    [Abstract] [Full Text] [Related]

  • 9. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 10. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.
    Cancer Res; 1999 Jul 15; 59(14):3365-8. PubMed ID: 10416595
    [Abstract] [Full Text] [Related]

  • 11. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S, Ohira M, Isogai E, Nakada K, Nakagawara A.
    Int J Oncol; 2004 Jun 15; 24(6):1457-66. PubMed ID: 15138588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Nagasaki A, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Eguchi H, Tsuneyoshi M.
    J Pediatr Surg; 2000 Dec 15; 35(12):1737-41. PubMed ID: 11101726
    [Abstract] [Full Text] [Related]

  • 15. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
    Hishiki T, Saito T, Terui K, Sato Y, Takenouchi A, Yahata E, Ono S, Nakagawara A, Kamijo T, Nakamura Y, Matsunaga T, Yoshida H.
    J Pediatr Surg; 2010 Dec 15; 45(12):2293-8. PubMed ID: 21129533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P.
    Cancer; 2002 Feb 01; 94(3):854-61. PubMed ID: 11857322
    [Abstract] [Full Text] [Related]

  • 18. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
    Kim CJ, Kim HO, Choe YJ, Lee YA, Kim CW.
    Anticancer Res; 1995 Feb 01; 15(5B):1997-2000. PubMed ID: 8572591
    [Abstract] [Full Text] [Related]

  • 19. [Tumor markers--personal experience. Ha-ras P21 in neuroblastoma: a new marker associating to patient's prognosis].
    Tanaka T.
    Gan To Kagaku Ryoho; 1991 Jan 01; 18(1):143-50. PubMed ID: 1987897
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.